Suppr超能文献

通过分子杂交方法获得的 1-(3',4',5'-三甲氧基苯基)-3-(2'-烷氧基羰基吲哚基)-2-丙烯-1-酮衍生物的设计、合成、体外增殖活性和诱导凋亡研究。

Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.

机构信息

a Department of Chemical and Pharmaceutical Sciences , University of Ferrara , Ferrara , Italy.

b Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research , National Cancer Institute, National Institutes of Health , Frederick , MD , USA.

出版信息

J Enzyme Inhib Med Chem. 2018 Dec;33(1):1225-1238. doi: 10.1080/14756366.2018.1493473.

Abstract

Inhibition of microtubule function using tubulin targeting agents has received growing attention in the last several decades. The indole scaffold has been recognized as an important scaffold in the design of novel compounds acting as antimitotic agents. Indole-based chalcones, in which one of the aryl rings was replaced by an indole, have been explored in the last few years for their anticancer potential in different cancer cell lines. Eighteen novel (3',4',5'-trimethoxyphenyl)-indolyl-propenone derivatives with general structure 9 were synthesized and evaluated for their antiproliferative activity against a panel of four different human cancer cell lines. The highest IC values were obtained against the human promyelocytic leukemia HL-60 cell line. This series of chalcone derivatives was characterized by the presence of a 2-alkoxycarbonyl indole ring as the second aryl system attached at the carbonyl of the 3-position of the 1-(3',4',5'-trimethoxyphenyl)-2-propen-1-one framework. The structure-activity relationship (SAR) of the indole-based chalcone derivatives was investigated by varying the position of the methoxy group, by the introduction of different substituents (hydrogen, methyl, ethyl or benzyl) at the N-1 position and by the activity differences between methoxycarbonyl and ethoxycarbonyl moieties at the 2-position of the indole nucleus. The antiproliferative activity data of the novel synthesized compounds revealed that generally N-substituted indole analogues exhibited considerably reduced potency as compared with their parent N-unsubstituted counterparts, demonstrating that the presence of a hydrogen on the indole nitrogen plays a decisive role in increasing antiproliferative activity. The results also revealed that the position of the methoxy group on the indole ring is a critical determinant of biological activity. Among the synthesized derivatives, compound 9e, containing the 2-methoxycarbonyl-6-methoxy-N-1H-indole moiety exhibited the highest antiproliferative activity, with IC values of 0.37, 0.16 and 0.17 μM against HeLa, HT29 and MCF-7 cancer cell lines, respectively, and with considerably lower activity against HL-60 cells (IC: 18 μM). This derivative also displayed cytotoxic properties (IC values ∼1 μM) in the human myeloid leukemia U-937 cell line overexpressing human Bcl-2 (U-937/Bcl-2) via cell cycle progression arrest at the G-M phase and induction of apoptosis. The results obtained also demonstrated that the antiproliferative activity of this molecule is related to inhibition of tubulin polymerisation. The presence of a methoxy group at the C5- or C6-position of the indole nucleus, as well as the absence of substituents at the N-1-indole position, contributed to the optimal activity of the indole-propenone-3',4',5'-trimethoxyphenyl scaffold.

摘要

几十年来,使用微管靶向剂抑制微管功能受到了越来越多的关注。吲哚骨架已被公认为设计作为抗有丝分裂剂的新型化合物的重要骨架。在过去的几年中,基于吲哚的查尔酮,其中一个芳环被吲哚取代,因其在不同癌细胞系中的抗癌潜力而被探索。合成了十八种新型(3',4',5'-三甲氧基苯基)-吲哚基丙烯酮衍生物,其通用结构为 9,并对其针对四种不同人类癌细胞系的抗增殖活性进行了评估。对人早幼粒细胞白血病 HL-60 细胞系的最高 IC 值。该系列查尔酮衍生物的特征在于存在 2-烷氧羰基吲哚环作为第二个芳基系统,连接在 1-(3',4',5'-三甲氧基苯基)-2-丙烯-1-酮框架的 3-位的羰基上。通过改变甲氧基的位置,通过在 N-1 位引入不同的取代基(氢,甲基,乙基或苄基)以及吲哚核 2-位甲氧基羰基和乙氧基羰基部分之间的活性差异,研究了基于吲哚的查尔酮衍生物的构效关系(SAR)。新型合成化合物的抗增殖活性数据表明,一般来说,与母体未取代的化合物相比,N-取代的吲哚类似物的效力明显降低,这表明吲哚氮上存在氢在增加抗增殖活性方面起着决定性作用。结果还表明,吲哚环上甲氧基的位置是决定生物活性的关键因素。在所合成的衍生物中,含有 2-甲氧羰基-6-甲氧基-N-1H-吲哚部分的化合物 9e 对 HeLa、HT29 和 MCF-7 癌细胞系的抗增殖活性最高,IC 值分别为 0.37、0.16 和 0.17 μM,对 HL-60 细胞的活性明显降低(IC:18 μM)。该衍生物在人髓样白血病 U-937 细胞系中也表现出细胞毒性特性(IC 值约为 1 μM),通过细胞周期停滞在 G-M 期和诱导细胞凋亡来过度表达人 Bcl-2(U-937/Bcl-2)。还证明了该分子的抗增殖活性与微管聚合的抑制有关。吲哚核的 C5-或 C6-位上存在甲氧基以及 N-1-吲哚位上没有取代基,有助于优化吲哚-丙烯酮-3',4',5'-三甲氧基苯基支架的活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b35/6116705/6cc1d4d6b1e8/IENZ_A_1493473_F0001_B.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验